MELA Sciences Inc  

(Public, NASDAQ:MELA)   Watch this stock  
Find more results for MELA
1.30
-0.01 (-0.76%)
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.29 - 1.39
52 week 1.14 - 8.90
Open 1.32
Vol / Avg. 67,643.00/64,946.00
Mkt cap 7.85M
P/E     -
Div/yield     -
EPS -2.95
Shares 6.04M
Beta -0.03
Inst. own 19%
Mar 16, 2015
Q4 2014 MELA Sciences Inc Earnings Release (Estimated) Add to calendar
Nov 12, 2014
Q3 2014 MELA Sciences Earnings Conference Call - Webcast
Nov 12, 2014
Q3 2014 MELA Sciences Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -1049.96% -4841.05%
Operating margin -1836.09% -4502.61%
EBITD margin - -3840.30%
Return on average assets -49.87% -165.27%
Return on average equity -82.07% -233.02%
Employees 45 -
CDP Score - -

Address

50 S Buckhout St Ste 1
IRVINGTON, NY 10533-2204
United States - Map
+1-914-5913783 (Phone)
+1-914-5913785 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care (in the doctor's office) instrument to aid in the detection of melanoma. MelaFind, features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions. The data are then analyzed utilizing classification algorithms, trained on the Company's database of melanomas and benign lesions, to provide information to assist in the management of the patient's disease, including information useful in the decision whether to biopsy the lesion.

Officers and directors

Jeffrey F. O'Donnell Sr. Chairman of the Board
Bio & Compensation  - Reuters
Michael R. Stewart President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Robert W. Cook Principal Financial Officer, Treasurer, Secretary
Age: 58
Bio & Compensation  - Reuters
Robert C. Coradini Director
Age: 54
Bio & Compensation  - Reuters
Tony Dimun Director
Age: 70
Bio & Compensation  - Reuters
David K. Stone Director
Age: 57
Bio & Compensation  - Reuters
Kathryn B. Swintek Director
Age: 61
Bio & Compensation  - Reuters
LuAnn Via Director
Age: 60
Bio & Compensation  - Reuters